Cargando…
Recent advances in genetically modified animal models of glaucoma and their roles in drug repositioning
Glaucoma is one of the leading causes of vision loss in the world. Currently, pharmacological intervention for glaucoma therapy is limited to eye drops that reduce intraocular pressure (IOP). Recent studies have shown that various factors as well as IOP are involved in the pathogenesis of glaucoma,...
Autores principales: | Harada, Chikako, Kimura, Atsuko, Guo, Xiaoli, Namekata, Kazuhiko, Harada, Takayuki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6362806/ https://www.ncbi.nlm.nih.gov/pubmed/30366949 http://dx.doi.org/10.1136/bjophthalmol-2018-312724 |
Ejemplares similares
-
Targeting Oxidative Stress for Treatment of Glaucoma and Optic Neuritis
por: Kimura, Atsuko, et al.
Publicado: (2017) -
Effects of lighting environment on the degeneration of retinal ganglion cells in glutamate/aspartate transporter deficient mice, a mouse model of normal tension glaucoma
por: Ohashi, Tsutomu, et al.
Publicado: (2022) -
Suppression of Oxidative Stress as Potential Therapeutic Approach for Normal Tension Glaucoma
por: Harada, Chikako, et al.
Publicado: (2020) -
Caloric restriction promotes cell survival in a mouse model of normal tension glaucoma
por: Guo, Xiaoli, et al.
Publicado: (2016) -
Differential effects of N-acetylcysteine on retinal degeneration in two mouse models of normal tension glaucoma
por: Sano, Hiroki, et al.
Publicado: (2019)